There is little information on CD34+DNAM-1brightCXCR4+ Inflammatory precursor entry in inflamed tissues and particularly into cancer tissue, while trafficking and developmental trajectory towards secondary lymphoid organs or thymus of conventional CD34+DNAM-1-CXCR4+ cells is well characterized. This evidence concerns the gene CD226 and cancer.